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ABSTRACT Bovine osteogenesis imperfecta is a congeni-
tal disease in Holstein cattle having several characteristics in
common with human osteogenesis imperfecta syndromes. In
particular, affected calves have multiple bone fractures and
friable teeth. Bone collagen isolated from the affected animals
(Texas variant) showed slightly decreased al(I) and a2(I)
chain electrophoretic mobility and increased hydroxylysine
content. Overall, collagen was present in the affected bones at
80-90% of normal values. However, osteonectin, a 32,000 Mr
bone-specific protein found previously to promote collagen
mineralization in vitro and present in abundance (-3% of total
protein) in normal calf bone, was severely depleted (<2% of
normal levels) in the osteogenesis imperfecta bone and dentin.
The bone proteoglycan was similarly depleted. In contrast, the
bone sialoprotein was not as severely affected. Further, the
diseased teeth lacked (<10% of normal values) phospho-
phoryn, a dentin-specific protein normally present as 4-5% of
the total calf dentin matrix. The data suggest multiple hard
tissue matrix protein deletions, perhaps due to impaired cell
development.
Osteogenesis imperfecta (01) is an Inherited disease of hu-
man bone that is heterogeneous in expression with degrees
of severity ranging from a perinatal lethal form to milder var-
iants with minimal clinical manifestations (1, 2). Affected in-
dividuals usually show bone fragility either with or without
concomitant growth deformities and can be classified as
nondeforming or progressively deforming occurring from ei-
ther dominant or recessive inheritance (3). The disease may
also be accompanied by fragile, opalescent teeth [dentino-
genesis imperfecta (DI)], blue sclerae, and joint laxity (1). 01
collagens are often present at lower levels than normal, with
apparently decreased fibril diameters (4, 5) and increased
hydroxylysine content (6). Analyses of cultures of skin biop-
sies from 01 patients have shown a wide range of collagen
abnormalities (7, 8) with the most severely affected individ-
uals (perinatal lethal form) having structural defects in type I
collagen (9-13). However, the type and extent of the skin
collagen abnormalities reported for other forms of OI in sur-
viving individuals do not universally reflect the severity or
extent of the underlying bone disease.
Until recently, no animal model for 01 had been studied,
although the disease had been reported occasionally in bo-
vine and ovine offspring (14-16). The bovine form of the dis-
ease has been described in offspring of an Australian bull
(17). More recently, a Texas bull has sired affected calves.
The latter affected calves have multiple intrauterine or post-
natal fractures (or both) of ribs, limbs, and mandibles. The
ultrastructure of the bones is hypercellular and porous with
characteristics of woven rather than lamellar bone. The os-
teoblasts were generally found to have dilated rough endo-
plasmic reticulum with no preferential orientation with re-
spect to the mineralization front (unpublished data). In both
cases, all affected calves have DI with markedly reduced
dentin including few and irregularly arranged tubules (17).
Joint laxity is common to all affected animals, whereas deep
blue sclerae have been more predominant in offspring from
the Texas sire (unpublished data). Dominant inheritance is
likely for both models based on crossbreeding experiments,
but disease frequency is higher (44% of progeny) in the Aus-
tralian than in the Texan variety (50% of progeny). The Tex-
as offspring appear to have the more severe osteopenia.
Previously, we established that several noncollagenous
matrix proteins are apparently specific to bone tissue. These
include osteonectin (18, 19), the bone proteoglycan (20), and
the bone sialoprotein (21). Osteonectin, a 32,000 Mr bone
glycoprotein, was shown to bind selectively to both hy-
droxyapatite and collagen. This protein also promoted min-
eral deposition onto type I collagen in vitro (19). Antibodies
to these bone proteins were used to demonstrate their tissue
specificity and matrix localization (19-21) and biosynthetic
studies have shown them to be products of osteoblast-like
cells (unpublished data). In this study, we examined bone
and dentin from the Texas-bred OI animals and report spe-
cific alterations in the noncollagenous proteins of these af-
fected tissues.
MATERIALS AND METHODS
Tissue Preparation. Affected offspring were obtained from
artificially inseminated Holstein and Angus cows. Affected
calves were identified at birth and sacrificed within 18 days.
Subperiosteal and central cortical bone was dissected from
long bones and mandibles of (i) OI Holstein-Holstein and
Holstein-Angus calves and (ii) their normal, age-matched
half-siblings or siblings. The dissected bone was washed ex-
tensively with phosphate-buffered saline containing protease
inhibitors (22). Aliquots of the washed bone were lyophi-
lized. Bone ash was determined after heating at 600'C for 24
hr. Dentin matrices were prepared from unerupted decidu-
ous molar teeth as described (22).
Characterization of Collagen. Lyophilized bone fragments
were powdered manually under liquid nitrogen and deminer-
alized by dialysis against 10% acetic acid. Duplicate portions
of the total demineralized bone from all calves were hydro-
lyzed in 6 M HCl at 1100C (24 hr) and amino acids were quan-
titated by automated methods (22). Collagen was solubilized
sequentially from the demineralized bone first with 0.5 M
Abbreviations: 01. osteogenesis imperfecta; DI, dentinogenesis im-
perfecta.
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acetic acid and then by pepsin digestion (1 mg of pepsin to 20
mg of demineralized bone) at 40C for 24 hr. Amino acid com-
positions of the purified collagens (in duplicate) were ob-
tained as described above.
Extraction and Fractionation of Noncollagenous Proteins.
Freshly dissected, washed hard tissue fragments were ex-
tracted sequentially first with 4 M guanidine HCl/0.05 M
Tris HCI, pH 7.4, containing protease inhibitors (G extract)
and then with an identical solution containing 0.5 M EDTA
(E extract) as described (18). Extracts were concentrated by
ultrafiltration (Amicon YM 5 or 10 filters). Aliquots were
desalted by Bio-Gel P-2 (Bio-Rad) chromatography in 0.1 M
formic acid and then lyophilized. The remainder of the bone
extracts were chromatographed on tandem Sepharose CL-
6B (Pharmacia) in 4 M guanidine HCl as described (18). Cor-
ollary extracts of the dentinal matrices were chromato-
graphed on DEAE-Sephacel (Pharmacia) in 7 M urea as de-
scribed (23). a
Analytical Methods. Aliquots of G and E extracts were
electrophoresed on NaDodSO4 gradient (4-20%) polyacryl-
amide slab gels as described by Laemmli (24) with only mi-
nor modifications (20). Five percent polyacrylamide slab
gels for collagen analyses were used exactly as described by
Laemmli (24). Quantitation of osteonectin, bone proteogly-
can, and bone sialoprotein was performed by ELISA as de-
scribed (19-21). Immunodetection of these bone-specific
proteins after transfer by electroblotting onto nitrocellulose
paper was performed by a modification of the method of
Towbin et al. (25) as described (21). Further, 150-,g samples
of extracts were prepared for bone proteoglycan immunode-
tection (electrophoretic transfer blot) after digestion of con-
stituent glycosaminoglycans with 10 mU of chondroitinase
ABC (Miles) for 1 hr at 37°C (20). (Intact proteoglycans do
not always electroblot efficiently under standard conditions,
whereas their core proteins transfer normally.)
RESULTS
The OI bones contained as much mineral as normal bones
based on their ash contents (Table 1). This is not unexpected
because woven and lamellar bones are known to be equal in
mineral content (26). The OI bones were exclusively woven
in structure and all woven bone is reported to mineralize via
matrix vesicles in interfibrillar spaces (26). The normal spec-
imens consisted entirely of lamellar bone in which mineral-
ization occurs primarily within the collagen fibrils (26).
However, the 01 bones apparently contained less protein
(Table 1). Amino acid analysis of the total demineralized
bone protein showed that the OI bone contained slightly less
collagen (6-10%) than normal, as indicated by reduced quan-
tities of hydroxyproline, proline, and glycine (Table 1). Ami-
no acid compositions from the purified normal and 01 bone
collagens (solubilized by pepsin digestion) were identical ex-
cept that the 01 samples contained more hydroxylysine and
concomitantly less lysine (Table 1). The acetic acid- and pep-
sin-soluble bone collagens were electrophoresed on 5% Na-
DodSO4/polyacrylamide slab gels (Fig. 1). The acid-soluble
bone collagen migrated slightly slower than the standard,
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FIG. 1. 5% NaDodSO4/polyacrylamide gel electrophoresis of
normal (N) and 01 bone collagens. Collagen liberated by acetic acid
extraction or pepsin digestion of demineralized bone was electro-
phoresed in comparison with standard lathyritic rat skin collagen
(LRSC). The bovine bone collagen migrated slightly slower than
LRSC, and the a chains of the 01 bone collagen had a lower mobility
than those of normal bone collagen. Treatment of the demineralized
bone with pepsin also liberated type V collagen as indicated by the
presence of al(V).
acid-soluble, lathrytic rat skin collagen. The 01 calf bone
collagens migrated somewhat slower than those from normal
calf bone, probably due to their increased lysine hydroxyl-
ation (27). No type III collagen was detected in any 01 or
normal bone sample upon treatment with delayed reduction
by dithiothreitol (data not shown). After pepsin digestion of
total OI or normal demineralized bone, small amounts of
type V collagen were observed (Fig. 1).
It was shown previously that sequential E extracts (guani-
dine.HCl/EDTA) are enriched in the bone-specific noncolla-
genous proteins (18, 20, 21). The extracts from femurs of
both normal and age-matched half-siblings with bovine OI
were chromatographed on molecular sieve columns. Typical
elution profiles are seen in Fig. 2. Although the level of the
serum-derived a2HS glycoprotein appeared to have in-
creased in the 01 bone (also see Fig. 3), the most striking
difference in the two profiles was a marked decrease in the
amount of protein eluting in the osteonectin region. Al-
though a slight decrease was seen in the column elution re-
gion of the 24,000 Mr bone phosphoprotein, this protein did
not appear altered on NaDodSO4 gels (Fig. 3). It should be
noted that some bone matrix components (e.g., bone pro-
teoglycan) do not have significant absorbance at 280 nm. Os-
teocalcin (a bone gla-containing protein) absorbance was
variable from specimen to specimen.
The absence of osteonectin was confirmed on reduced,
NaDodSO4/polyacrylamide gradient gels as shown in Fig. 3.
Osteonectin, which migrates in this particular gradient gel
Table 1. Compositional analysis of normal and 01 bovine bone
Amino acid composition, residues per 1000 residues
Ash Protein
content, content, Demieralized bone Collagen
Bone n* to %t Hyp Pro Gly Hyp + Pro Hyl Lys Hyl/(Hyl + Lys)
Normal 2 63 ± 2 26 ± 3 114 ± 1 119 ± 1 305 ± 1 233 12 ± 2 24 ± 1 0.33
01 3 66 ± 2 15 ± 3 103 ± 2 106 ± 2 285 ± 2 209 17 ± 1 20 ± 2 0.46
01/normal 1.05 0.58 0.90 0.93 0.94 - - 1.39
Where indicated, values are expressed as mean ± SD.
*n = Number of calves studied.
tNondialyzable material remaining after demineralization.
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FIG. 2. Elution profiles of the E extracts from 01 and half-sibling
control, midshaft cortical bone chromatographed on Sepharose CL-
6B columns in 4 M guanidine HCl. Typical peak positions of authen-
tic bone proteins are depicted for al and a2 collagens, bone proteo-
glycan (BPG), a2HS glycoprotein (a2HS), osteonectin (ON), 24,000
Mr bone phosphoprotein (BPP), bone sialoprotein (BSP), and osteo-
calcin (OC).
system as a 40,000 Mr species, was prominent in the E ex-
tract of both the Holstein-Holstein and the Holstein-Angus
normal bones but was apparently missing in the E extracts
from bones of their 01 half-siblings. These results were con-
sistent for the four Texas OI calves examined to date. Im-
munoreplicas (electrophoretic transfer blots) of these Na-
DodSO4 gels showed that detectable amounts of osteonectin
were still present in the 01 bones but at a drastically reduced
level (Fig. 4). After isoelectric focusing, these same extracts
were electrotransferred onto nitrocellulose. Immunodetec-
tion of osteonectin in these replicas yielded identical doublet
bands for both the normal calf osteonectin and the small
amount of osteonectin present in the OI extracts, suggesting
that the reactive 01 protein was identical to normal osteo-
nectin (data not shown).
The G extracts from both the normal and affected bone
specimens were electrophoresed to determine whether the
osteonectin missing from the 01 bone E extracts was re-
moved in the initial (G) extractions. Fig. 3 shows that the G-
extract patterns were very similar, with no excess staining in
the osteonectin region. In addition, electrophoretic transfer
blots (immunoreplicas) of these gels actually showed a de-
crease in the small amounts of osteonectin released in the 01
G extract relative to normal (Fig. 4), thus confirming the re-
sults seen for the E-extract proteins.
The amount of osteonectin missing from the 01 bone ma-
trices was quantitated by using competition ELISA analysis.
Osteonectin levels in the total bone extracts (G + E) from
the four affected calves were 1.2% (+0.9%) of the levels
found in their normal, age-matched half-siblings. The bone
proteoglycan was also affected significantly in the 01 calves.
Although alcian blue-staining bone proteoglycan bands (20)
were observed in NaDodSO4 gels of OI bone extracts, the
intensity relative to normal was markedly diminished (Fig.
3). Immunodetection of the electroblotted proteoglycan core
protein (Fig. 4) further demonstrated the marked decrease in
the bone proteoglycan content found in the 01 bone extracts.
Competition ELISA analysis showed that OI bone extracts
(G + E) contained only 6.5% (±2.7%) of the bone proteogly-
FIG. 3. NaDodSO4 gradient (4-20%) polyacrylamide gels of nor-
mal (N) and 01 cortical bone extracts. The initial guanidine HCl
(G) and the subsequent guanidine HCl/EDTA (E) extracts were co-
stained with Coomassie and Alcian blue. Band positions of authentic
bone proteins (20) are shown for type I al (upper) and a2 (lower)
collagen chains, bone proteoglycan (BPG), bone sialoprotein (BSP),
a2HS glycoprotein (a2HS), osteonectin (ON), 24,000 Mr bone phos-
phoprotein (BPP), and osteocalcin (OC). The molecular weight stan-
dards (shown as Mr x 10-') include (top to bottom): ,B-galactosidase,
phosphorylase B, bovine serum albumin, ovalbumin, carbonic anhy-
drase, trypsin inhibitor, and a-lactalbumin. Ho, Holstein-Holstein;
An, Holstein-Angus.
can levels found in total bone extracts from the normal con-
trols. The bone sialoprotein appeared less severely affected
in the bovine 01 tissues on gel filtration (Fig. 2) and on Na-
DodSO4 gels (Fig. 3). Competition ELISA analysis of the
total 01 bone extracts (G + E) showed that bone sialoprotein
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FIG. 4. Horseradish peroxidase-conjugated indirect immunode-
tection of osteonectin (ON) and the bone proteoglycan (BPG) core
protein (PG-C, obtained after removal of glycosaminoglycan chains
with chondroitinase ABC) on nitrocellulose electroblots of Na-
DodSO4 gels containing both normal (N) and 01 cortical bone ex-
tracts. Note the positive but decreased response in the lanes con-
taining the 01 samples. Arrows indicate the locations of authentic
osteonectin and bone proteoglycan core protein. Ho and An, as in
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FIG. 5. Elution profile of the E extracts of control and 01 dentin
on DEAE-Sephacel in 7 M urea. The symbols On and DPP locate
typical elution positions for dentinal osteonectin and the dentin
phosphophoryn, respectively. Pooled fractions of peak I were ana-
lyzed for osteonectin-like proteins by ELISA analysis. Peak II frac-
tions contained dentin phosphophoryn as determined by amino acid
analysis and electrophoretic gels. Each fraction contained 1.3 ml.
The affected animals in this study all exhibited DI. The
enamel protein distribution and content in the affected ani-
mals was found to be normal and was not studied further.
The normal and affected dentin extracts (processed sequen-
tially in a manner identical to that of the cortical bone) were
chromatographed on DEAE-Sephacel as shown in Fig. 5.
The DI profiles showed a marked decrease in dentin phos-
phophoryn, the major noncollagenous protein of dentin (Fig.
5, peak II). This was confirmed on amino acid analysis (den-
tin phosphophoryn contains serine and aspartate as 80% of
total residues; ref. 23) and on NaDodSO4 gel electrophoresis
using Stains All (Bio-Rad) detection (data not shown). Nor-
mal dentin also contains an osteonectin-like protein that
elutes in the peak I position of Fig. 5, a region also depressed
in the DI extracts. This was confirmed by competition
ELISA analyses. The osteonectin-like protein of dentin is at
least 50% crossreactive with osteonectin (unpublished data).
Peak I of the DI dentin had <1% of osteonectin-equivalent
activity relative to the same fractions from normal controls.
DISCUSSION
Human 01 has been thought to involve genetic alterations
primarily in collagen expression (28). Indeed, many of the
collagen data described in this report are consistent with ear-
lier studies of collagen in human 01 tissue, including de-
creased type I collagen content, increased hydroxylysine/ly-
sine ratios, and slightly slower electrophoretic mobility rela-
tive to normal bone collagens. Preliminary data on procolla-
gens synthesized by osteoblasts cultured from bovine OI
bone did not show any detectable structural differences from
control tissue (unpublished data). This is in contrast to re-
sults described for human 01 type II variants (9, 11-13) and a
single case of 01 type I (10) in which defective collagen a
chain biosynthesis is well documented (28). Thus, the bovine
form of 01 may be similar to other forms of human Ol in
which collagen structural gene abnormalities are not well un-
derstood (29).
This study demonstrates that several noncollagenous calf
bone matrix proteins, each of which also exists in human
bone, are severely depleted in bovine 01 bone and dentin.
The 01 bone samples contained only 1.2% of the osteonectin
and 6.5% of the proteoglycan found in normal tissue, where-
as the sialoprotein was less affected (48.9% of normal). In
the DI dentin, phosphophoryn and the osteonectin-like pro-
tein were each <10% of normal. Dentin phosphophoryn, a
100,000 Mr noncollagenous matrix protein accounting for 4-
5% of the total protein in developing calf dentin (23), is char-
acteristic of normal (tubular) dentin in all species studied.
The phosphophoryn deficiency in human DI has been sug-
gested earlier (30).
It is not clear, at present, how these three proteins are
linked in this disease. Nevertheless, it is obvious that these
are the major hard tissue proteins affected in the bovine 01
syndrome and thus are significant manifestations of the dis-
ease. Although there was no biochemical evidence of matrix
degradation, biosynthetic studies are needed to decide
whether the osteonectin, bone proteoglycan, and phospho-
phoryn deficiencies noted reflect synthetic or degradative
phenomena. However, in view of the apparent specificity of
these deletions (a2HS glycoprotein, for example is not de-
graded), synthetic defects are suspected.
One interesting hypothesis that may explain the data is
that the abnormal bovine 01 tissues may reflect arrested de-
velopment. The overall 01 bone morphology, for example, is
that of primitive, woven bone. Embryonic collagens general-
ly have increased lysine hydroxylation (27, 31) and small-
diameter collagen fibrils similar to those seen for OI bone (4,
5), and it is possible that these changes might affect subse-
quent interaction with other bone proteins. However, only a
slightly decreased osteonectin content was observed for the
woven bone of early fetal calves (unpublished data). In an
analogous fashion, dentin phosphophoryn is a normal con-
stituent of mature, tubular dentin. It is not certain whether
this protein is equally distributed in the atubular, mantle den-
tin formed earlier in tooth germ development. Thus, the hard
tissue aspects of this disease may represent a failure of the
osteoblast to mature and produce normal lamellar bone and
of the odontoblast to produce mature dentin. Because more
than one tissue system is clinically affected (e.g., bone, den-
tin, sclera), it is possible that a defect in a circulating fac-
tor(s) or its receptor(s) is responsible for differentiation or
maturation (or both) of these diverse tissues and may under-
lie the observed abnormalities. In any event, the findings de-
scribed above present new challenges in the evaluation of
this inherited bone disease syndrome.
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